Literature DB >> 11336919

Homocysteine decreases chondrocyte-mediated matrix mineralization in differentiating chick limb-bud mesenchymal cell micro-mass cultures.

M Khan1, M Yamauchi, S Srisawasdi, D Stiner, S Doty, E P Paschalis, A L Boskey.   

Abstract

The differentiating chick limb-bud mesenchymal cell micro-mass culture system has been used as a model for monitoring the effects of matrix modification on cell-mediated calcification. In this study, we show that treating these micro-mass cultures with homocysteine (Hcys) impairs cartilage calcification. Cultures were treated from day 2 to day 7 with two nonphysiological concentrations of Hcys equivalent to 100x and 1000x avian serum levels (0.36 and 3.6 mmol/L), and from days 9-13 with one tenth the concentration. Mineralization assays were done at days 16, 19, and 21, and matrix and cell properties were examined between days 5 and 21. Mineral accretion, based on differential (45)Ca uptake (mineralizing minus control cultures), was significantly reduced in the high-Hcys-concentration group, and slightly reduced in the low-Hcys-concentration group. Electron microscopy at culture day 21 showed that the collagen matrix was less abundant and its banding pattern less obvious in the Hcys-treated groups than in the untreated cultures. Pyridinoline (Pyr) and deoxypyridinoline (d-Pyr) contents were not detectable in day 21 cultures with either 0.36 or 3.6 mmol/L homocysteine, whereas values in mineralizing and nonmineralizing controls ranged from 0.06 to 0.08 and 0.03 to 0.06 (moles/mole collagen) for Pyr and d-Pyr, respectively. Fourier transform infrared (FTIR) imaging also indicated a decreased content of pyridinoline cross-links. Hcys caused other matrix changes as well. Whereas at culture day 5 there was no significant difference in the number of chondrocyte nodules formed, by day 11 the proteoglycan content (measured by Alcian blue dye binding at 595 nm) was significantly reduced in both mineralizing and control cultures in the high- and low-Hcys groups. In contrast, there were no detectable differences in type X collagen and alkaline phosphatase staining in the mineralizing cultures with or without Hcys supplements. Because vital dye stains and electron microscopy studies indicated that cells in the control and experimental groups did not differ in terms of viability, the observed differences cannot be attributed to toxicity. Thus, Hcys treatment, which causes matrix disorganization, decreases the ability of the matrix to support mineralization.

Entities:  

Keywords:  Non-programmatic

Mesh:

Substances:

Year:  2001        PMID: 11336919     DOI: 10.1016/s8756-3282(01)00409-4

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  15 in total

Review 1.  The role of the gasotransmitter hydrogen sulfide in pathological calcification.

Authors:  Mariela Castelblanco; Sonia Nasi; Andreas Pasch; Alexander So; Nathalie Busso
Journal:  Br J Pharmacol       Date:  2019-07-24       Impact factor: 8.739

2.  Relation of plasma total homocysteine, folate and vitamin B12 levels to bone mineral density in Moroccan healthy postmenopausal women.

Authors:  Zhor Ouzzif; Khalid Oumghar; Karim Sbai; Aziza Mounach; El Mustapha Derouiche; Abdellah El Maghraoui
Journal:  Rheumatol Int       Date:  2010-07-31       Impact factor: 2.631

Review 3.  Homocysteine as a Pathological Biomarker for Bone Disease.

Authors:  Jyotirmaya Behera; Jyoti Bala; Mohammed Nuru; Suresh C Tyagi; Neetu Tyagi
Journal:  J Cell Physiol       Date:  2017-04-12       Impact factor: 6.384

4.  Association of red blood cell 5-methyltetrahydrofolate folate with bone mineral density in postmenopausal Iranian women.

Authors:  J Golbahar; M A Aminzadeh; S A Hamidi; G R Omrani
Journal:  Osteoporos Int       Date:  2005-08-23       Impact factor: 4.507

5.  The link between osteoporosis and cardiovascular disease.

Authors:  Ghada N Farhat; Jane A Cauley
Journal:  Clin Cases Miner Bone Metab       Date:  2008-01

6.  The relation of plasma homocysteine to radiographic knee osteoarthritis.

Authors:  M Fayfman; J Niu; Y Q Zhang; D T Felson; B Sack; P Aliabadi; J Selhub; D J Hunter
Journal:  Osteoarthritis Cartilage       Date:  2008-11-30       Impact factor: 6.576

7.  Association of Methylene Tetrahydrofolate Reductase Polymorphism with BMD and Homocysteine in Premenopausal North Indian Women.

Authors:  Sanjeev Kumar Pandey; Ankur Singh; Sunil Kumar Polipalli; Sangeeta Gupta; Seema Kapoor
Journal:  J Clin Diagn Res       Date:  2013-12-15

8.  Strontium ranelate decreases plasma homocysteine levels in postmenopausal osteoporotic women.

Authors:  Ilhan Bayhan; Dilek Uygur; Nil Ugurlu; Gulnur Ozaksit
Journal:  Rheumatol Int       Date:  2008-09-26       Impact factor: 2.631

Review 9.  Biochemical assessment of bone turnover and bone fragility in men.

Authors:  P Szulc; J M Kaufman; P D Delmas
Journal:  Osteoporos Int       Date:  2007-06-14       Impact factor: 4.507

10.  The synergistic effect of bone mineral density and methylenetetrahydrofolate reductase (MTHFR) polymorphism (C677T) on fractures.

Authors:  Masataka Shiraki; Tomohiko Urano; Tatsuhiko Kuroda; Mitsuru Saito; Shiro Tanaka; Mariko Miyao-Koshizuka; Satoshi Inoue
Journal:  J Bone Miner Metab       Date:  2008-11-01       Impact factor: 2.626

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.